SCHEMBL135879

SCHEMBL135879

C[C@@H](OC(=O)[C@@H](N)CO)[C@H](N)C(=O)O

nearest known ligand 0.41

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
SLC7A5 Q01650 2/20 0.41
USP2 O75604 1/20 0.38
SLCO1B1 Q9Y6L6 1/20 0.38
SLC1A1 P43005 4/20 0.36
SLC1A3 P43003 4/20 0.36
SLC1A2 P43004 4/20 0.36
CASR P41180 1/20 0.34
KIF11 P52732 1/20 0.32
TGFBR1 P36897 1/20 0.32
P2RY10 O00398 2/20 0.32
GPR174 Q9BXC1 2/20 0.32
PTGS1 P23219 1/20 0.31
SLC7A11 Q9UPY5 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1537267 1.00 SLC7A5 (0.41) SLC7A5USP2SLCO1B1SLC1A1SLC1A3
Valine SCHEMBL4409191 0.95 SLC7A5 (0.52) SLC7A5USP2SLCO1B1SLC1A1SLC1A3
SCHEMBL7730688 0.92 SLC7A5 (0.35) SLC7A5USP2SLCO1B1SLC1A1SLC1A3
Serine SCHEMBL10612187 0.86 SLC7A5 (0.45) SLC7A5USP2SLCO1B1SLC1A1SLC1A3
SCHEMBL5704260 0.84 NOS3 (0.36) SLC7A5USP2SLCO1B1SLC1A1SLC1A3
SCHEMBL28554464 0.83 SLC7A5 (0.40) SLC7A5SLC1A1SLC1A3SLC1A2CASR
SCHEMBL1497690 0.83 PTGS1 (0.48) SLC7A5SLC1A1SLC1A3SLC1A2CASR
SCHEMBL891923 0.83 SLC7A5 (0.55) SLC7A5SLC1A1SLC1A3SLC1A2CASR
SCHEMBL4255881 0.83 GSR (0.45)
SCHEMBL1964052 0.81 SLC7A5 (0.39) SLC7A5SLC1A1SLC1A3SLC1A2CASR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 97 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9090669-B2 Short fatty acid tail polymyxin derivatives and uses thereof NORTHERN ANTIBIOTICS LTD. (FI) 2015-07-28 US claimed
WO-1981000577-A1 NUCLEOTIDIC SEQUENCE CODING THE SURFACE ANTIGEN OF THE HEPATITIS B VIRUS,VECTOR CONTAINING SAID NUCLEOTIDIC SEQUENCE,PROCESS ALLOWING THE OBTENTION THEREOF AND ANTIGEN OBTAINED THEREBY PASTEUR INSTITUT (FR) 1981-03-05 WO claimed
US-20230285520-A1 DEVELOPMENT OF A NEW ENGINEERED TOBACCO ETCH VIRUS (TEV) PROTEASE ACTIVABLE IN THE CYTOSOL OR SECRETORY PATHWAY Università Cattolica del Sacro Cuore (IT) 2023-09-14 US disclosed
EP-4189092-A1 DEVELOPMENT OF A NEW ENGINEERED TOBACCO ETCH VIRUS (TEV) PROTEASE ACTIVABLE IN THE CYTOSOL OR SECRETORY PATHWAY Universita' Cattolica Del Sacro Cuore (IT) 2023-06-07 EP disclosed
WO-2022023963-A1 DEVELOPMENT OF A NEW ENGINEERED TOBACCO ETCH VIRUS (TEV) PROTEASE ACTIVABLE IN THE CYTOSOL OR SECRETORY PATHWAY Università Cattolica del Sacro Cuore (IT) 2022-02-03 WO disclosed
EP-3400006-B1 VACCINE STRAINS OF BRACHYSPIRA HYODYSENTERIAE UNIV GENT (BE) 2022-02-02 EP disclosed
US-10821165-B2 Vaccine strains of brachyspira hyodysenteriae UNIVERSITEIT GENT (BE) 2020-11-03 US disclosed
CN-107312047-B Method for synchronously separating and preparing salidroside and rosavin from rhodiola rosea 中国科学院兰州化学物理研究所 2020-05-01 CN disclosed
CN-110506055-A Engineered TfR combination polypeptide DENALI THERAPEUTICS INC 2019-11-26 CN disclosed
CN-110506054-A Engineered polypeptide DENALI THERAPEUTICS INC 2019-11-26 CN disclosed
CN-109476751-A ANTI-TIM-3 ANTIBODIES AND METHODS OF USE THEREOF 艾吉纳斯公司 2019-03-15 CN disclosed
CN-1165612-A Method for cultivating lumeikes feed crops XIONG JUNGONG (CN) 1997-11-26 CN disclosed
WO-1994017186-A1 NOVEL GENES, POLYPEPTIDES, AND COMPOSITIONS FOR COLD TOLERANCE AND DROUGHT RESISTANCE IN PLANTS RESEARCH CORPORATION TECHNOLOGIES, INC. (US) 1994-08-04 WO disclosed
EP-0540586-A1 BINDING DOMAINS CAMBRIDGE ANTIBODY TECHNOLOGY LIMITED (GB) 1993-05-12 EP disclosed
EP-0500589-A1 PURIFIED PROTEIN AND BIOACTIVE PHARMACEUTICAL. ALFACELL CORP (US) 1992-09-02 EP disclosed
WO-1992001787-A1 BINDING DOMAINS CAMBRIDGE ANTIBODY TECHNOLOGY LIMITED (GB) 1992-02-06 WO disclosed
EP-0350506-A4 PULMONARY SURFACTANT PROTEIN AND RELATED POLYPEPTIDE 1992-01-22 EP disclosed
WO-1991007435-A1 PURIFIED PROTEIN AND BIOACTIVE PHARMACEUTICAL ALFACELL CORPORATION (US) 1991-05-30 WO disclosed
EP-0350506-A1 PULMONARY SURFACTANT PROTEIN AND RELATED POLYPEPTIDE THE SCRIPPS RESEARCH INSTITUTE (US) 1990-01-17 EP disclosed
WO-1989006657-A1 PULMONARY SURFACTANT PROTEIN AND RELATED POLYPEPTIDE SCRIPPS CLINIC AND RESEARCH FOUNDATION (US) 1989-07-27 WO disclosed